Michal Marom, a director at $ORA, sold 3,080 shares of the company on 05-19-2026 for an estimated $403,403. We received data on the trade from a recent SEC filing. This was a sale of approximately 63.6% of their shares of this class of stock. Following this trade, they now own 1,766 shares of this class of $ORA stock.
$ORA Insider Trading Activity
$ORA insiders have traded $ORA stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $ORA stock by insiders over the last 6 months:
- ASSI GINZBURG (Chief Financial Officer) has made 0 purchases and 2 sales selling 17,776 shares for an estimated $2,395,233.
- OFER BENYOSEF (EVP, Energy Storage & BD) sold 9,429 shares for an estimated $1,235,387
- JESSICA WOELFEL (GC, CCO, and CS) has made 0 purchases and 6 sales selling 7,291 shares for an estimated $785,815.
- BYRON G. WONG sold 4,500 shares for an estimated $604,440
- DAVID GRANOT has made 0 purchases and 2 sales selling 3,519 shares for an estimated $470,017.
- MICHAL MAROM sold 3,080 shares for an estimated $403,403
- STANLEY STERN sold 577 shares for an estimated $75,108
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ORA Hedge Fund Activity
We have seen 209 institutional investors add shares of $ORA stock to their portfolio, and 202 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- IMPAX ASSET MANAGEMENT GROUP PLC removed 1,086,369 shares (-61.6%) from their portfolio in Q4 2025, for an estimated $120,011,183
- CANADA PENSION PLAN INVESTMENT BOARD added 528,435 shares (+49.6%) to their portfolio in Q1 2026, for an estimated $59,142,445
- JPMORGAN CHASE & CO removed 350,211 shares (-68.8%) from their portfolio in Q4 2025, for an estimated $38,687,809
- WELLINGTON MANAGEMENT GROUP LLP removed 336,847 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $37,699,916
- ENCOMPASS CAPITAL ADVISORS LLC removed 312,675 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $34,994,586
- BLACKROCK, INC. added 309,177 shares (+3.3%) to their portfolio in Q1 2026, for an estimated $34,603,089
- HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. added 282,583 shares (+32.7%) to their portfolio in Q1 2026, for an estimated $31,626,689
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ORA Revenue
$ORA had revenues of $403.9M in Q1 2026. This is an increase of 75.8% from the same period in the prior year.
You can track ORA financials on Quiver Quantitative's ORA stock page.
You can access data on ORA stock through the Quiver Quantitative API.
$ORA Analyst Ratings
Wall Street analysts have issued reports on $ORA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/15/2026
- TD Cowen issued a "Buy" rating on 01/09/2026
To track analyst ratings and price targets for $ORA, check out Quiver Quantitative's $ORA forecast page.
$ORA Price Targets
Multiple analysts have issued price targets for $ORA recently. We have seen 10 analysts offer price targets for $ORA in the last 6 months, with a median target of $130.0.
Here are some recent targets:
- Derek Podhaizer from Piper Sandler set a target price of $142.0 on 05/18/2026
- David Anderson from Barclays set a target price of $126.0 on 05/08/2026
- Mark Strouse from JP Morgan set a target price of $123.0 on 05/08/2026
- Jon Windham from UBS set a target price of $152.0 on 05/08/2026
- Christopher Dendrinos from RBC Capital set a target price of $130.0 on 03/03/2026
- Ben Kallo from Baird set a target price of $130.0 on 02/27/2026
- Ryan Levine from Citigroup set a target price of $128.0 on 02/18/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.